Estradiol-induced Down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression

https://doi.org/10.1016/0960-0760(94)90072-8Get rights and content

Abstract

Incubation of MCF-7 cells with estradiol (E2) down-regulates estrogen receptor (ER) resulting in a progressive reduction of the capacity of cells to concentrate selectively [3H]E2. Scatchard plot analysis failed to detect any transformation of residual receptors into peptides of lower binding affinity. [3H]Estrone gave an identical ER disappearance pattern with an ER half-life comprised between 2 and 3 h. A similar value was established by incubating the cells with [3H]tamoxifenaziridine ([3H]TAZ) for 1 h before the addition of excessive unlabeled E2 which induced ER-down regulation and impeded any further labeling of the residual receptors. Submission of the [3H]TAZ labeled cell extracts to SDS-PAGE revealed no progressive emergence of low molecular weight cleavage products of the receptor (< 67 kDa). Two inhibitors of protein kinases, H-7 at 40 μM and H-89 at 20 μM, failed to block the E2-induced ER down-regulation. On the contrary, the protein phosphatases 1 and 2A inhibitor, okadaic acid, was effective with concentrations higher than 0.1 μM indicating that a dephosphorylation mechanism was involved in this phenomenon. Cycloheximide (CHX) also significantly reduced the receptor decrease at concentrations higher than 1μM. G-C specific intercalating agents [actinomycin D (AMD) and chromomycin A3 at 1 μM] also prevented ER disappearance; ethidium bromide (EB) and quinacrine were ineffective. AMD and CHX operated immediately after their addition to the medium indicating an inhibitory acttion on the synthesis of an RNA and/or a peptide with high turnover rate involved in ER decline. Moreover, AMD produced its suppressive effects under conditions impeding any labeling of newly synthetized receptors (i.e. [3H]TAZ with an excess of unlabeled E2) rejecting the possibility of an increasing ER production which may partially hamper its disappearance. Finally, E2-induced ER mRNA down-regulation was similarly abolished by AMD while EB and CHX were devoid of effect.

References (59)

  • M.L. Brock et al.

    Estrogen stabilizes vitellogenin mRNA against cytoplasmic degradation

    Cell

    (1983)
  • A.T. Riegel et al.

    Transcriptional and post-transcriptional inhibition of albumin gene expression by estrogen in Xenopus liver

    Molec. Cell. Endocr.

    (1986)
  • M.T. Chong et al.

    Effects of RNA and ribonuclease on the binding of estrogen and glucocorticoid receptors from MCF-7 cells to DNA cellulose

    J. Biol. Chem.

    (1982)
  • D.G. Hardie et al.

    Use of okadaic acid to inhibit protein phosphatases in intact cells

    Meth. Enzym.

    (1991)
  • R. Graber et al.

    Rapid and long-term effects of 17β-estradiol on PIP2-Phospholipase C-specific activity of MCF-7 cells

    Cell. Signal

    (1993)
  • C.V. Mobbs et al.

    PLC-α: a common mediator of the action of estrogen and other hormones?

    Molec. Cell. Endocr.

    (1991)
  • J.C. Tsibris et al.

    Selective inhibition of protein disulfide isomerase by estrogens

    J. Biol. Chem.

    (1989)
  • R.M. Evans

    The steroid and thyroid hormone receptor superfamily

    Science

    (1988)
  • M.A. Carson-Jurica et al.

    Steroid receptor family: structure and functions

    Endocrine Rev.

    (1990)
  • K.R. Yamamoto

    Steroid receptor regulated transcription of specific genes and gene networks

    A. Rev. Genet.

    (1985)
  • S. Green et al.

    The oestrogen receptor: from perception to mechanisme

  • M. Beato

    Transcriptional control by nuclear receptors

    FASEB J.

    (1991)
  • A. Kasid et al.

    A novel nuclear form of estradiol receptor in MCF-7 human breast cancer cells

    Science

    (1984)
  • R. Jakesz et al.

    Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells

    Cancer Res.

    (1984)
  • N. Guilbaud et al.

    Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells

    J. Cell. Physiol.

    (1990)
  • W.R. Bezwoda et al.

    Effect of α-interferon, 17β-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF-7 cells

    Cancer Res.

    (1990)
  • B.L. Maxwell et al.

    Structural organization and regulation of the chicken estrogen receptor

    Molec. Endocr.

    (1987)
  • A.M. Nardulli et al.

    Dynamics of estrogen receptor turnover in uterine cells in vitro and uteri in vivo

    Endocrinology

    (1986)
  • L.L. Wei et al.

    Multiple human progesterone receptor messenger ribonucleic acids and their autoregulation by progestin agonist and antagonist in breast cancer cells

    Molec. Endocr.

    (1988)
  • Cited by (0)

    View full text